196 TLR9-activated B cells directly license adoptively transferred CD8+ T cells with potent tumor immunity

Aubrey Smith; Hannah Knochelmann; Megan Wyatt; Guillermo Rangel RIvera; Brandon Ware; Amalia Rivera Reyes; Connor Dwyer; David Neskey; Mark Rubinstein; Bei Liu; Jessica Thaxton; Eric Bartee; Chrystal Paulos

doi:10.1136/jitc-2021-SITC2021.196

Article info

PDF

Regular and Young Investigator Award Abstracts

Cellular Therapies

196 TLR9-activated B cells directly license adoptively transferred CD8+ T cells with potent tumor immunity

Free

Authors

Aubrey Smith Medical University of South Carolina, Charleston, SC, USA; Emory University, Decatur, GA, USA PubMed articles Google scholar articles
Hannah Knochelmann Medical University of South Carolina, Charleston, SC, USA PubMed articles Google scholar articles
Megan Wyatt Emory University, Decatur, GA, USA PubMed articles Google scholar articles
Guillermo Rangel RIvera Emory University, Decatur, GA, USA PubMed articles Google scholar articles
Brandon Ware Emory University, Decatur, GA, USA PubMed articles Google scholar articles
Amalia Rivera Reyes Emory University, Decatur, GA, USA PubMed articles Google scholar articles
Connor Dwyer Medical University of South Carolina, Charleston, SC, USA PubMed articles Google scholar articles
David Neskey Medical University of South Carolina, Charleston, SC, USA PubMed articles Google scholar articles
Mark Rubinstein Medical University of South Carolina, Charleston, SC, USA PubMed articles Google scholar articles
Bei Liu Medical University of South Carolina, Charleston, SC, USA PubMed articles Google scholar articles
Jessica Thaxton Medical University of South Carolina, Charleston, SC, USA PubMed articles Google scholar articles
Eric Bartee University of New Mexico, Albuquerque, NM, USA PubMed articles Google scholar articles
Chrystal Paulos Emory University, Decatur, GA, USA PubMed articles Google scholar articles

Citation

Smith A, Knochelmann H, Wyatt M, et al

196 TLR9-activated B cells directly license adoptively transferred CD8+ T cells with potent tumor immunity

Journal for ImmunoTherapy of Cancer 2021;9:doi: 10.1136/jitc-2021-SITC2021.196

Publication history

First published November 10, 2021.

Online issue publication

March 30, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password